Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Knight

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2020
Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?Thomas G Knight
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Interventions for Financial Toxicity: More Crucial Than Ever in the Time of COVID-19Thomas G Knight
Best Practice & Research. Clinical Haematology|June 23, 2023
Financial toxicity in patients with leukemia undergoing hematopoietic stem cell transplantation: A systematic reviewOrrin Pail, Thomas G Knight
Current Hematologic Malignancy Reports|July 25, 2023
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for InterventionsMegan Sears-Smith, Thomas G Knight
JCO Oncology Practice|July 15, 2024
Mental Health Matters: Bringing Awareness to the Less Recognized Financial Toxicities of Cancer CareMegan Sears-Smith, Thomas G Knight
Journal of Oncology Practice|October 26, 2018
Financial Toxicity in Adults With Cancer: Adverse Outcomes and NoncomplianceThomas G Knight, Allison M Deal, Stacie B Dusetzina, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 16, 2020
Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematologyLucas S Wind, Thomas G Knight, Jessica J Auten, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2025
The Financial Toxicity Tumor Board: 5-Year Update on Practice and a Guide to ImplementationThomas G Knight, Caitlin Hensel, Kris Blackley, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2020
Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?Thomas G Knight
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Interventions for Financial Toxicity: More Crucial Than Ever in the Time of COVID-19Thomas G Knight
Best Practice & Research. Clinical Haematology|June 23, 2023
Financial toxicity in patients with leukemia undergoing hematopoietic stem cell transplantation: A systematic reviewOrrin Pail, Thomas G Knight
Current Hematologic Malignancy Reports|July 25, 2023
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for InterventionsMegan Sears-Smith, Thomas G Knight
JCO Oncology Practice|July 15, 2024
Mental Health Matters: Bringing Awareness to the Less Recognized Financial Toxicities of Cancer CareMegan Sears-Smith, Thomas G Knight
Journal of Oncology Practice|October 26, 2018
Financial Toxicity in Adults With Cancer: Adverse Outcomes and NoncomplianceThomas G Knight, Allison M Deal, Stacie B Dusetzina, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 16, 2020
Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematologyLucas S Wind, Thomas G Knight, Jessica J Auten, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2025
The Financial Toxicity Tumor Board: 5-Year Update on Practice and a Guide to ImplementationThomas G Knight, Caitlin Hensel, Kris Blackley, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Pageof 2